Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies.

Santos K, Palmini A, Radziuk AL, Rotert R, Bastos F, Booij L, Fernandes BS.

Dev Med Child Neurol. 2013 Jul;55(7):654-60. doi: 10.1111/dmcn.12121. Epub 2013 Mar 9.

PMID:
23480530
[PubMed - indexed for MEDLINE]
2.

Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.

Yoo HK, Park S, Wang HR, Lee JS, Kim K, Paik KW, Yum MS, Ko TS.

Epileptic Disord. 2009 Dec;11(4):301-8. doi: 10.1684/epd.2009.0278. Epub 2009 Dec 15.

PMID:
20007067
[PubMed - indexed for MEDLINE]
3.

The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies.

Brunklaus A, Dorris L, Zuberi SM.

Dev Med Child Neurol. 2013 Oct;55(10):966-7. doi: 10.1111/dmcn.12192. Epub 2013 Jun 3. No abstract available.

PMID:
23725490
[PubMed - indexed for MEDLINE]
4.

Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities.

Gucuyener K, Erdemoglu AK, Senol S, Serdaroglu A, Soysal S, Kockar AI.

J Child Neurol. 2003 Feb;18(2):109-12.

PMID:
12693777
[PubMed - indexed for MEDLINE]
5.

Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.

van der Feltz-Cornelis CM, Aldenkamp AP.

Epilepsy Behav. 2006 May;8(3):659-62. Epub 2006 Feb 28. Erratum in: Epilepsy Behav. 2006 Nov;9(3):542.

PMID:
16504592
[PubMed - indexed for MEDLINE]
6.

Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit.

Fosi T, Lax-Pericall MT, Scott RC, Neville BG, Aylett SE.

Epilepsia. 2013 Dec;54(12):2071-81. Review.

PMID:
24304474
[PubMed - indexed for MEDLINE]
7.

Remission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate.

Chou WJ, Chen SJ, Chen YS, Liang HY, Lin CC, Tang CS, Huang YS, Yeh CB, Chou MC, Lin DY, Hou PH, Wu YY, Liu HJ, Huang YF, Hwang KL, Chan CH, Pan CH, Chang HL, Huang CF, Hsu JW.

J Child Adolesc Psychopharmacol. 2012 Jun;22(3):215-25. doi: 10.1089/cap.2011.0006. Epub 2012 Apr 26.

PMID:
22537358
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The open-label treatment of attention-deficit/hyperactivity disorder in 4- and 5-year-old children with beaded methylphenidate.

Maayan L, Paykina N, Fried J, Strauss T, Gugga SS, Greenhill L.

J Child Adolesc Psychopharmacol. 2009 Apr;19(2):147-53.

PMID:
19374023
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Optimizing therapy of seizures in children and adolescents with ADHD.

Aldenkamp AP, Arzimanoglou A, Reijs R, Van Mil S.

Neurology. 2006 Dec 26;67(12 Suppl 4):S49-51. Review.

PMID:
17190923
[PubMed - indexed for MEDLINE]
10.

Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.

Polanczyk G, Zeni C, Genro JP, GuimarĂ£es AP, Roman T, Hutz MH, Rohde LA.

Arch Gen Psychiatry. 2007 Feb;64(2):218-24.

PMID:
17283289
[PubMed - indexed for MEDLINE]
11.

An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.

Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez-Heydrich J.

Expert Opin Investig Drugs. 2008 Jan;17(1):77-84. Review.

PMID:
18095920
[PubMed - indexed for MEDLINE]
12.

Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.

Simonoff E, Taylor E, Baird G, Bernard S, Chadwick O, Liang H, Whitwell S, Riemer K, Sharma K, Sharma SP, Wood N, Kelly J, Golaszewski A, Kennedy J, Rodney L, West N, Walwyn R, Jichi F.

J Child Psychol Psychiatry. 2013 May;54(5):527-35. doi: 10.1111/j.1469-7610.2012.02569.x. Epub 2012 Jun 7.

PMID:
22676856
[PubMed - indexed for MEDLINE]
13.

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.

Soutullo C, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Bloomfield R, Squires LA, Coghill DR.

CNS Drugs. 2013 Sep;27(9):743-51. doi: 10.1007/s40263-013-0086-6.

PMID:
23801529
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.

Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L; RUPP ADHD/Anxiety Study Group.

J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):418-27.

PMID:
15843763
[PubMed - indexed for MEDLINE]
15.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
[PubMed - indexed for MEDLINE]
16.

Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.

Mohammadi MR, Hafezi P, Galeiha A, Hajiaghaee R, Akhondzadeh S.

Acta Med Iran. 2012 Nov;50(11):723-8.

PMID:
23292622
[PubMed - indexed for MEDLINE]
Free Article
17.

Epilepsy in a large cohort of children diagnosed with attention deficit/hyperactivity disorders (ADHD).

Socanski D, Aurlien D, Herigstad A, Thomsen PH, Larsen TK.

Seizure. 2013 Oct;22(8):651-5. doi: 10.1016/j.seizure.2013.04.021. Epub 2013 May 24.

PMID:
23711613
[PubMed - indexed for MEDLINE]
18.

Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?

Gross-Tsur V, Manor O, van der Meere J, Joseph A, Shalev RS.

J Pediatr. 1997 Apr;130(4):670-4.

PMID:
9432523
[PubMed - indexed for MEDLINE]
19.

Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?

Gross-Tsur V, Manor O, van der Meere J, Joseph A, Shalev RS.

J Pediatr. 1997 Jan;130(1):40-4. Corrected and republished in: J Pediatr. 1997 Apr;130(4):670-4.

PMID:
9003849
[PubMed - indexed for MEDLINE]
20.

Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension.

Ginsberg Y, Lindefors N.

Br J Psychiatry. 2012 Jan;200(1):68-73. doi: 10.1192/bjp.bp.111.092940. Epub 2011 Nov 10.

PMID:
22075648
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk